Your browser doesn't support javascript.
loading
A phase II study of bortezomib in combination with pegylated liposomal doxorubicin for acute myeloid leukemia.
Tomlinson, Benjamin K; Tuscano, Joseph M; Abedi, Mehrdad; Welborn, Jeanna; Arora, Mili; O'Donnell, Robert T; Wun, Ted; Jonas, Brian A.
Afiliação
  • Tomlinson BK; Seidman Cancer Center, Case Comprehensive Cancer Center, Cleveland, Ohio.
  • Tuscano JM; Division of Hematology and Oncology, University of California Davis Comprehensive Cancer Center, Sacramento, California.
  • Abedi M; Division of Hematology and Oncology, University of California Davis Comprehensive Cancer Center, Sacramento, California.
  • Welborn J; Division of Hematology and Oncology, University of California Davis Comprehensive Cancer Center, Sacramento, California.
  • Arora M; Division of Hematology and Oncology, University of California Davis Comprehensive Cancer Center, Sacramento, California.
  • O'Donnell RT; Division of Hematology and Oncology, University of California Davis Comprehensive Cancer Center, Sacramento, California.
  • Wun T; Division of Hematology and Oncology, University of California Davis Comprehensive Cancer Center, Sacramento, California.
  • Jonas BA; Division of Hematology and Oncology, University of California Davis Comprehensive Cancer Center, Sacramento, California.
Am J Hematol ; 94(11): E291-E294, 2019 11.
Article em En | MEDLINE | ID: mdl-31379016
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Protocolos de Quimioterapia Combinada Antineoplásica Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Protocolos de Quimioterapia Combinada Antineoplásica Idioma: En Ano de publicação: 2019 Tipo de documento: Article